SELLAS Life Sciences Group, Inc. (SLS)
12.41
+0.48
(+4.02%)
USD |
NASDAQ |
Oct 13, 16:00
12.44
+0.03
(+0.24%)
After-Hours: 04:27
SELLAS Life Sciences Group EPS Diluted (TTM) : -0.2121 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2121 |
| March 31, 2026 | -0.2283 |
| December 31, 2025 | -0.2458 |
| September 30, 2025 | -0.2869 |
| June 30, 2025 | -0.3284 |
| March 31, 2025 | -0.391 |
| December 31, 2024 | -0.5383 |
| September 30, 2024 | -0.7005 |
| June 30, 2024 | -0.9232 |
| March 31, 2024 | -1.105 |
| December 31, 2023 | -1.363 |
| September 30, 2023 | -1.544 |
| June 30, 2023 | -1.559 |
| March 31, 2023 | -1.662 |
| December 31, 2022 | -2.244 |
| September 30, 2022 | -2.225 |
| June 30, 2022 | -2.329 |
| March 31, 2022 | -2.217 |
| December 31, 2021 | -1.325 |
| September 30, 2021 | -1.192 |
| June 30, 2021 | -1.277 |
| March 31, 2021 | -1.634 |
| December 31, 2020 | -2.122 |
| September 30, 2020 | -3.300 |
| June 30, 2020 | -5.448 |
| Date | Value |
|---|---|
| March 31, 2020 | -11.11 |
| December 31, 2019 | -21.59 |
| September 30, 2019 | -50.37 |
| June 30, 2019 | -74.44 |
| March 31, 2019 | -131.12 |
| December 31, 2018 | -203.49 |
| September 30, 2018 | -173.25 |
| June 30, 2018 | -3551.02 |
| March 31, 2018 | -10237.98 |
| December 31, 2017 | -15599.46 |
| September 30, 2017 | -15599.46 |
| June 30, 2017 | -13095.03 |
| March 31, 2017 | -5444.97 |
| December 31, 2016 | -2700.27 |
| September 30, 2016 | -5503.75 |
| June 30, 2016 | -7903.99 |
| March 31, 2016 | -11804.38 |
| December 31, 2015 | -11504.35 |
| September 30, 2015 | -8700.87 |
| June 30, 2015 | -6900.69 |
| March 31, 2015 | -9000.90 |
| December 31, 2014 | -7200.72 |
| September 30, 2014 | -21002.10 |
| June 30, 2014 | -22802.28 |
| March 31, 2014 | -21002.10 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| ImmunityBio, Inc. | -0.9692 |
| AbbVie, Inc. | 3.537 |
| TG Therapeutics, Inc. | 2.746 |
| Capricor Therapeutics, Inc. | -2.449 |
| Relay Therapeutics, Inc. | -1.567 |